360 related articles for article (PubMed ID: 34757590)
1. Targeting Tau Mitigates Mitochondrial Fragmentation and Oxidative Stress in Amyotrophic Lateral Sclerosis.
Petrozziello T; Bordt EA; Mills AN; Kim SE; Sapp E; Devlin BA; Obeng-Marnu AA; Farhan SMK; Amaral AC; Dujardin S; Dooley PM; Henstridge C; Oakley DH; Neueder A; Hyman BT; Spires-Jones TL; Bilbo SD; Vakili K; Cudkowicz ME; Berry JD; DiFiglia M; Silva MC; Haggarty SJ; Sadri-Vakili G
Mol Neurobiol; 2022 Jan; 59(1):683-702. PubMed ID: 34757590
[TBL] [Abstract][Full Text] [Related]
2. Novel genetic variants in MAPT and alterations in tau phosphorylation in amyotrophic lateral sclerosis post-mortem motor cortex and cerebrospinal fluid.
Petrozziello T; Amaral AC; Dujardin S; Farhan SMK; Chan J; Trombetta BA; Kivisäkk P; Mills AN; Bordt EA; Kim SE; Dooley PM; Commins C; Connors TR; Oakley DH; Ghosal A; Gomez-Isla T; Hyman BT; Arnold SE; Spires-Jones T; Cudkowicz ME; Berry JD; Sadri-Vakili G
Brain Pathol; 2022 Mar; 32(2):e13035. PubMed ID: 34779076
[TBL] [Abstract][Full Text] [Related]
3. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage.
Manczak M; Reddy PH
Hum Mol Genet; 2012 Jun; 21(11):2538-47. PubMed ID: 22367970
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis.
Joshi AU; Saw NL; Vogel H; Cunnigham AD; Shamloo M; Mochly-Rosen D
EMBO Mol Med; 2018 Mar; 10(3):. PubMed ID: 29335339
[TBL] [Abstract][Full Text] [Related]
5. Significance of CSF NfL and tau in ALS.
Schreiber S; Spotorno N; Schreiber F; Acosta-Cabronero J; Kaufmann J; Machts J; Debska-Vielhaber G; Garz C; Bittner D; Hensiek N; Dengler R; Petri S; Nestor PJ; Vielhaber S
J Neurol; 2018 Nov; 265(11):2633-2645. PubMed ID: 30187162
[TBL] [Abstract][Full Text] [Related]
6. Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis.
Grossman M; Elman L; McCluskey L; McMillan CT; Boller A; Powers J; Rascovsky K; Hu W; Shaw L; Irwin DJ; Lee VM; Trojanowski JQ
JAMA Neurol; 2014 Apr; 71(4):442-8. PubMed ID: 24492862
[TBL] [Abstract][Full Text] [Related]
7. Tau protein as a diagnostic and prognostic biomarker in amyotrophic lateral sclerosis.
Agnello L; Colletti T; Lo Sasso B; Vidali M; Spataro R; Gambino CM; Giglio RV; Piccoli T; Bivona G; La Bella V; Ciaccio M
Eur J Neurol; 2021 Jun; 28(6):1868-1875. PubMed ID: 33638255
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Mitochondrial Dysfunction in Amyotrophic Lateral Sclerosis.
Zhao J; Wang X; Huo Z; Chen Y; Liu J; Zhao Z; Meng F; Su Q; Bao W; Zhang L; Wen S; Wang X; Liu H; Zhou S
Cells; 2022 Jun; 11(13):. PubMed ID: 35805131
[TBL] [Abstract][Full Text] [Related]
9. Increased Tau Phosphorylation in Motor Neurons From Clinically Pure Sporadic Amyotrophic Lateral Sclerosis Patients.
Stevens CH; Guthrie NJ; van Roijen M; Halliday GM; Ooi L
J Neuropathol Exp Neurol; 2019 Jul; 78(7):605-614. PubMed ID: 31131395
[TBL] [Abstract][Full Text] [Related]
10. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases.
Reddy PH; Reddy TP; Manczak M; Calkins MJ; Shirendeb U; Mao P
Brain Res Rev; 2011 Jun; 67(1-2):103-18. PubMed ID: 21145355
[TBL] [Abstract][Full Text] [Related]
11. Chronic cerebral hypoperfusion accelerates Alzheimer's disease pathology with the change of mitochondrial fission and fusion proteins expression in a novel mouse model.
Feng T; Yamashita T; Zhai Y; Shang J; Nakano Y; Morihara R; Fukui Y; Hishikawa N; Ohta Y; Abe K
Brain Res; 2018 Oct; 1696():63-70. PubMed ID: 29879414
[TBL] [Abstract][Full Text] [Related]
12. Evidence of mitochondrial dysfunction in ALS and methods for measuring in model systems.
Lee J; Pye N; Ellis L; Vos K; Mortiboys H
Int Rev Neurobiol; 2024; 176():269-325. PubMed ID: 38802177
[TBL] [Abstract][Full Text] [Related]
13. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
Reddy PH; Oliver DM
Cells; 2019 May; 8(5):. PubMed ID: 31121890
[TBL] [Abstract][Full Text] [Related]
14. Targeting dynamin-related protein-1 as a potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease.
Bhatti JS; Kaur S; Mishra J; Dibbanti H; Singh A; Reddy AP; Bhatti GK; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166798. PubMed ID: 37392948
[TBL] [Abstract][Full Text] [Related]
15. Dynamin-related protein 1: A critical protein in the pathogenesis of neural system dysfunctions and neurodegenerative diseases.
Qi Z; Huang Z; Xie F; Chen L
J Cell Physiol; 2019 Jul; 234(7):10032-10046. PubMed ID: 30515821
[TBL] [Abstract][Full Text] [Related]
16. Increased mitochondrial antioxidative activity or decreased oxygen free radical propagation prevent mutant SOD1-mediated motor neuron cell death and increase amyotrophic lateral sclerosis-like transgenic mouse survival.
Liu R; Li B; Flanagan SW; Oberley LW; Gozal D; Qiu M
J Neurochem; 2002 Feb; 80(3):488-500. PubMed ID: 11905995
[TBL] [Abstract][Full Text] [Related]
17. Loss of mitofusin 2 links beta-amyloid-mediated mitochondrial fragmentation and Cdk5-induced oxidative stress in neuron cells.
Park J; Choi H; Min JS; Kim B; Lee SR; Yun JW; Choi MS; Chang KT; Lee DS
J Neurochem; 2015 Mar; 132(6):687-702. PubMed ID: 25359615
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria-targeted catalase reverts the neurotoxicity of hSOD1G⁹³A astrocytes without extending the survival of ALS-linked mutant hSOD1 mice.
Pehar M; Beeson G; Beeson CC; Johnson JA; Vargas MR
PLoS One; 2014; 9(7):e103438. PubMed ID: 25054289
[TBL] [Abstract][Full Text] [Related]
19. Age-dependent increase in tau phosphorylation at serine 396 in Huntington's disease pre-frontal cortex.
Petrozziello T; Huntress SS; Castillo-Torres AL; Quinn JP; Connors TR; Auger CA; Mills AN; Kim SE; Liu S; Mahmood F; Boudi A; Wu M; Sapp E; Kivisäkk P; Sunderesh SR; Pouladi MA; Arnold SE; Hyman BT; Rosas HD; DiFiglia M; Pinto RM; Kegel-Gleason K; Sadri-Vakili G
medRxiv; 2023 Jun; ():. PubMed ID: 37333415
[TBL] [Abstract][Full Text] [Related]
20. ALS-associated mutation SOD1
Wang H; Yi J; Li X; Xiao Y; Dhakal K; Zhou J
Bone; 2018 Jan; 106():126-138. PubMed ID: 29030231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
